24/7 eTV BreakingNews Show : Danna maɓallin ƙara (hagu na hagu na allon bidiyo)
Breaking Labaran Turai Breaking Labaran Duniya Yanke Labaran Balaguro Tafiya Kasuwanci Labaran Gwamnati Rahoton Lafiya Ƙasar Abincin Labarai mutane Sake ginawa Hakkin Rasha Breaking News Safety Technology Tourism Labaran Wayar Balaguro trending Yanzu

WHO ba za ta amince da allurar rigakafin COVID-19 na Rasha kan keta haddin samarwa ba

WHO ba za ta amince da allurar rigakafin COVID-19 na Rasha kan keta haddin samarwa ba
WHO ba za ta amince da allurar rigakafin COVID-19 na Rasha kan keta haddin samarwa ba
Written by Harry Johnson

Hukumar ta WHO a baya ta ba da rahoton cewa ta sami keta haddi da yawa kuma tana da damuwar da ta shafi “aiwatar da isassun matakai don rage hadarin kamuwa da giciye” a masana'antar Pharmstandard da ke garin Ufa na Rasha.

Print Friendly, PDF & Email
  • Hukumar Lafiya ta Duniya ta dakatar da amincewar gaggawa na allurar Sputnik V COVID-19 da Rasha ta yi.
  • HO ta gano ƙetare ƙimar masana'antu da yawa a masana'antar samarwa a Ufa, Rasha.
  • Za a buƙaci sabon duba kayan aikin kafin a ba da izinin gaggawa, in ji WHO.

Mataimakin Daraktan Hukumar Lafiya ta Duniya (WHO) Jarbas Barbosa ya ba da sanarwar cewa yunƙurin Rasha na ba da izinin gaggawa na allurar Sputnik V COVID-19 da kungiyar ta yi bayan da aka gano wasu ƙetare abubuwan da aka yi yayin binciken WHO a Rasha.

Mataimakin Daraktan Hukumar Lafiya ta Duniya (WHO) Jarbas Barbosa

Yayin wani taron manema labarai na Kungiyar Lafiya ta Pan American, reshen yanki na WHO, Barbosa ya ce an dakatar da aikin ba da izinin gaggawa har zuwa lokacin da za a sake duba sabbin masana’antar Rasha guda daya da ke kera allurar.

“Tsarin don Sputnik VAn dakatar da lissafin amfani da gaggawa (EUL) saboda yayin da suke duba daya daga cikin shuke -shuken da ake kera allurar, sun gano cewa shuka ba ta yarda da mafi kyawun ayyukan masana'antu ba, ”in ji Barbosa.

Hukumar ta WHO a baya ta ba da rahoton cewa ta sami keta haddi da yawa kuma tana da damuwar da ta shafi “aiwatar da isassun matakai don rage hadarin kamuwa da giciye” a masana'antar Pharmstandard da ke garin Ufa na Rasha.

Bayan wallafa sakamakon binciken na hukumar ta WHO, kamfanin ya ce tuni ta magance damuwar su kuma masu dubawar ba su yi shakkar aminci ko ingancin allurar ba. Amma, a cewar masana kimiya masu zaman kansu da masu binciken masana’antu, keta haddin kera na iya yin illa ga ingancin allurar. 

The World Health Organization ya ce har yanzu yana jiran sabuntawa daga Pharmstandard kuma ya ba da shawarar za a buƙaci sabon binciken kayan aikin kafin WHO ta ba da izinin Sputnik V.

“Mai samarwa yana buƙatar ɗaukar wannan a ƙarƙashin shawara, yin canje -canjen da suka dace, kuma a shirye don sabon binciken. WHO na jiran mai kera ya aiko da labarai cewa shukarsu ta yi daidai, ”in ji Barbosa.

Rasha ta gabatar da aikace -aikacen ta don amincewa daga WHO da Hukumar Magunguna ta Turai (EMA) a watan Fabrairu.

Amma tayin ya ci karo da matsaloli da yawa.

Dukansu Hukumar Kula da Magunguna ta Turai (EMA) da WHO sun ce a makon da ya gabata har yanzu suna jiran “cikakken bayanan bayanai” daga masu haɓaka Sputnik V. 

Samun yarda daga kowace ƙungiya yana da matuƙar mahimmanci ga Rasha, wacce ta ƙaddamar da shirin diflomasiyya na allurar rigakafin cutar kuma ta sayar da miliyoyin allurai ga ƙasashe da dama. Hakanan zai buɗe hanya don yuwuwar fahimtar juna tsakanin alluran rigakafin, sauƙaƙe balaguron bala'in bayan bala'in ga mutanen Rasha da aka yi musu allurar rigakafi. Sputnik V.

Print Friendly, PDF & Email

Game da marubucin

Harry Johnson

Harry Johnson ya kasance editan aikin eTurboNews na kusan shekaru 20. Yana zaune a Honolulu, Hawaii, kuma asalinsa daga Turai ne. Yana jin daɗin rubutu da ɗaukar labarai.

Leave a Comment